Pfizer CEO Profits After COVID Vaccine Announcement

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

design
Where Design Meets Durability: Why Commercial Surfaces Must Support Safety, Cleanability, and Long-Term Value
June 8, 2026

When a commercial space fails, it often fails quietly: a lobby floor that becomes slippery when wet, a hotel bathroom that is difficult to clean, a healthcare surface that cannot withstand constant disinfection, or an office finish that looks great until afternoon glare makes the room uncomfortable. These are not purely aesthetic problems; they are…

Read More
creative career
Crafted Journey How To: Building a Creative Career Across Scripts, Stages, and Sound
June 8, 2026

Creative careers rarely move in a straight line, especially for writers working across stage, screen, audio, books, and independent film. Sustaining that kind of life often means finding opportunities wherever they appear, building a strong network, staying open to different formats, and saying yes to collaborations that can lead somewhere unexpected. The stakes are…

Read More
EMR
EMR Strategy, Consulting, and Career Pivots with MedSys Co-Founder Mark Embry
June 8, 2026

Electronic medical records (EMRs) have moved from a back-office upgrade to a frontline determinant of care quality, clinician burnout, and hospital economics. With U.S. hospitals often spending tens to hundreds of millions—sometimes exceeding $100 million—on EMR implementations, the stakes have never been higher for getting both the technology and the human adoption right. As…

Read More
radiology
Growing Without Compromise: How Vision Radiology Balances Scale, AI, and Clinical Quality
June 4, 2026

Radiology sits at the center of a modern healthcare squeeze: imaging volumes are climbing, hospitals need faster reads, and there simply are not enough radiologists to meet demand the old way. At the same time, remote work and AI are reshaping what a clinical practice can look like. The challenge is no longer whether…

Read More